Danaher Corporation $DHR Shares Sold by Mawer Investment Management Ltd.

Mawer Investment Management Ltd. lowered its position in Danaher Corporation (NYSE:DHR) by 6.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 370,579 shares of the conglomerate’s stock after selling 23,607 shares during the quarter. Mawer Investment Management Ltd. owned 0.05% of Danaher worth $84,833,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC acquired a new position in Danaher in the 3rd quarter worth $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the 4th quarter worth $26,000. WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher in the 3rd quarter worth $27,000. Finally, Financial Life Planners acquired a new stake in shares of Danaher in the 3rd quarter valued at about $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on DHR shares. Guggenheim cut their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. cut their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Wells Fargo & Company cut their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 target price on shares of Danaher in a research note on Friday, April 17th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $238.24.

Danaher Price Performance

DHR opened at $180.07 on Tuesday. The firm has a market cap of $127.45 billion, a price-to-earnings ratio of 34.83, a price-to-earnings-growth ratio of 2.44 and a beta of 0.81. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company’s 50-day moving average price is $181.91 and its 200 day moving average price is $207.20. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.88 earnings per share. As a group, sell-side analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.